{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:57:29Z","timestamp":1791597449109,"version":"4.3.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":74,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006013","name":"United Arab Emirates University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alzheimer\u2019s disease (AD) causes progressive cognitive decline, and current therapies provide limited benefit. This study evaluated the neuroprotective effects of lenalidomide (LLM), a thalidomide derivative, in a scopolamine-induced mouse model of cognitive impairment, with emphasis on its acetylcholinesterase (AChE) inhibitory potential. Mice received LLM (5, 10, and 20\u00a0mg\/kg), donepezil (DNP) (3\u00a0mg\/kg), or a combination and were assessed using Y-maze, passive avoidance, novel object recognition, and Morris water maze tests. In silico analysis, including molecular docking, 100\u00a0ns molecular dynamics simulation and ADMET profiling were performed to investigate the interaction of LLM with AChE. Memory performance showed a significant and dose-dependent improvement after the treatment of LLM. The 20\u00a0mg\/kg dose exhibited effects comparable to DNP. LLM and DNP work together to increase effectiveness. Docking and simulation analyses revealed strong, stable binding to AChE while ADMET values indicated good drug-likeness. LLM exhibits neuroprotective and cognition enhancing effects in the scopolamine-induced model. In silico study also shows its potential as an AChE inhibitor. The study\u2019s anti-inflammatory mechanisms might also be helpful but need more exploration.<\/jats:p>","DOI":"10.1038\/s41598-026-49461-8","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T11:14:04Z","timestamp":1779534844000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lenalidomide ameliorates cognitive impairment via putative AChE inhibition: an in silico and in vivo study in a scopolamine-induced cognitive impairment model"],"prefix":"10.1038","volume":"16","author":[{"given":"Salehin","family":"Sheikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md.","family":"Shadin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanzila Akter","family":"Eity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Most. Israt Jahan","family":"Oni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mst Muslima","family":"Khatun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raihan","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Shimul","family":"Bhuia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alfaifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal H.","family":"Altemani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah H.","family":"Altemani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na\u2019il","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Torequl","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"issue":"1","key":"49461_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-019-0609-7","volume":"27","author":"LK Huang","year":"2020","unstructured":"Huang, L. K., Chao, S. P. & Hu, C. J. Clinical trials of new drugs for Alzheimer disease. J. Biomed. Sci. 27(1), 18. https:\/\/doi.org\/10.1186\/s12929-019-0609-7 (2020).","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"49461_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12050","volume":"6","author":"J Cummings","year":"2020","unstructured":"Cummings, J., Lee, G., Ritter, A., Sabbagh, M. & Zhong, K. Alzheimer\u2019s disease drug development pipeline: 2020. Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions 6(1), e12050. https:\/\/doi.org\/10.1002\/trc2.12050 (2020).","journal-title":"Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions"},{"key":"49461_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/9783527805921.ch12","author":"N Braidy","year":"2017","unstructured":"Braidy, N., Poljak, A., Jayasena, T. & Sachdev, P. Natural plant-derived acetylcholinesterase inhibitors: relevance for Alzheimer\u2019s disease. Natural Products Targeting Clinically Relevant Enzymes https:\/\/doi.org\/10.1002\/9783527805921.ch12 (2017).","journal-title":"Natural Products Targeting Clinically Relevant Enzymes"},{"issue":"2","key":"49461_CR4","first-page":"96","volume":"99","author":"J Lemi\u00e8re","year":"1999","unstructured":"Lemi\u00e8re, J., Van Gool, D. & Dom, R. Treatment of Alzheimer\u2019s disease: An evaluation of the cholinergic approach. Acta Neurol. Belg. 99(2), 96\u2013106 (1999).","journal-title":"Acta Neurol. Belg."},{"key":"49461_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115438","volume":"295","author":"V Singh","year":"2022","unstructured":"Singh, V. et al. Trimethoxyflavones from Ocimum basilicum L. leaves improve long term memory in mice by modulating multiple pathways. J. Ethnopharmacol. 295, 115438. https:\/\/doi.org\/10.1016\/j.jep.2022.115438 (2022).","journal-title":"J. Ethnopharmacol."},{"issue":"4558","key":"49461_CR6","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1126\/science.7046051","volume":"217","author":"RT Bartus","year":"1982","unstructured":"Bartus, R. T., Dean, R. L. III., Beer, B. & Lippa, A. S. The cholinergic hypothesis of geriatric memory dysfunction. Science 217(4558), 408\u2013414. https:\/\/doi.org\/10.1126\/science.7046051 (1982).","journal-title":"Science"},{"issue":"8","key":"49461_CR7","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1615\/IntJMedMushrooms.2019031508","volume":"21","author":"A Kaur","year":"2019","unstructured":"Kaur, A., Randhawa, K., Singh, V. & Shri, R. Bioactivity-guided isolation of acetylcholinesterase inhibitor from Ganoderma mediosinense (Agaricomycetes). Int. J. Med. Mushrooms 21(8), 755\u2013763. https:\/\/doi.org\/10.1615\/IntJMedMushrooms.2019031508 (2019).","journal-title":"Int. J. Med. Mushrooms"},{"issue":"1","key":"49461_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-13920-5","volume":"15","author":"D Kaur","year":"2025","unstructured":"Kaur, D. et al. Neuroprotective effect of tozasertib in streptozotocin-induced Alzheimer\u2019s mice model. Sci. Rep. 15(1), 28963. https:\/\/doi.org\/10.1038\/s41598-025-13920-5 (2025).","journal-title":"Sci. Rep."},{"issue":"1","key":"49461_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11064-023-04009-4","volume":"49","author":"P Sood","year":"2024","unstructured":"Sood, P., Singh, V. & Shri, R. Morus alba fruit extract and its fractions ameliorate streptozotocin induced cognitive deficit in mice via modulating oxidative and cholinergic systems. Neurochem. Res. 49(1), 52\u201365. https:\/\/doi.org\/10.1007\/s11064-023-04009-4 (2024).","journal-title":"Neurochem. Res."},{"key":"49461_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115144","volume":"165","author":"MH Mahnashi","year":"2023","unstructured":"Mahnashi, M. H. et al. Polyphenol-enriched Desmodium elegans DC. ameliorate scopolamine-induced amnesia in animal model of Alzheimer\u2019s disease: In vitro, in vivo and in silico approaches. Biomed. Pharmacother. 165, 115144. https:\/\/doi.org\/10.1016\/j.biopha.2023.115144 (2023).","journal-title":"Biomed. Pharmacother."},{"issue":"16","key":"49461_CR11","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1080\/14786419.2017.1356838","volume":"32","author":"S Bernardini","year":"2018","unstructured":"Bernardini, S., Tiezzi, A., Laghezza Masci, V. & Ovidi, E. Natural products for human health: An historical overview of the drug discovery approaches. Nat. Prod. Res. 32(16), 1926\u20131950. https:\/\/doi.org\/10.1080\/14786419.2017.1356838 (2018).","journal-title":"Nat. Prod. Res."},{"issue":"1","key":"49461_CR12","doi-asserted-by":"publisher","first-page":"5594462","DOI":"10.1155\/2024\/5594462","volume":"2024","author":"TA Eity","year":"2024","unstructured":"Eity, T. A. et al. Therapeutic efficacy of quercetin and its nanoformulation both the mono\u2010or combination therapies in the management of cancer: An update with molecular mechanisms. J. Trop. Med. 2024(1), 5594462. https:\/\/doi.org\/10.1155\/2024\/5594462 (2024).","journal-title":"J. Trop. Med."},{"issue":"4","key":"49461_CR13","doi-asserted-by":"publisher","first-page":"388","DOI":"10.2174\/1570159X11311040004","volume":"11","author":"AP Murray","year":"2013","unstructured":"Murray, A. P., Faraoni, M. B., Castro, M. J., Alza, N. P. & Cavallaro, V. Natural AChE inhibitors from plants and their contribution to Alzheimer\u2019s disease therapy. Curr. Neuropharmacol. 11(4), 388\u2013413. https:\/\/doi.org\/10.2174\/1570159X11311040004 (2013).","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"49461_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-2-36","volume":"2","author":"V Kotla","year":"2009","unstructured":"Kotla, V. et al. Mechanism of action of lenalidomide in hematological malignancies. J. Hematol. Oncol. 2(1), 36. https:\/\/doi.org\/10.1186\/1756-8722-2-36 (2009).","journal-title":"J. Hematol. Oncol."},{"issue":"21","key":"49461_CR15","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1182\/blood-2015-07-567958","volume":"126","author":"EC Fink","year":"2015","unstructured":"Fink, E. C. & Ebert, B. L. The novel mechanism of lenalidomide activity. Blood 126(21), 2366\u20132369. https:\/\/doi.org\/10.1182\/blood-2015-07-567958 (2015).","journal-title":"Blood"},{"issue":"9","key":"49461_CR16","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1200\/JCO.2007.14.5367","volume":"26","author":"AA Chanan-Khan","year":"2008","unstructured":"Chanan-Khan, A. A. & Cheson, B. D. Lenalidomide for the treatment of B-cell malignancies. J. Clin. Oncol. 26(9), 1544\u20131552. https:\/\/doi.org\/10.1200\/JCO.2007.14.5367 (2008).","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"49461_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12974-015-0320-x","volume":"12","author":"E Valera","year":"2015","unstructured":"Valera, E., Mante, M., Anderson, S., Rockenstein, E. & Masliah, E. Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson\u2019s disease. J. Neuroinflammation 12(1), 93. https:\/\/doi.org\/10.1186\/s12974-015-0320-x (2015).","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"49461_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s40262-016-0432-1","volume":"56","author":"N Chen","year":"2017","unstructured":"Chen, N., Zhou, S. & Palmisano, M. Clinical pharmacokinetics and pharmacodynamics of lenalidomide. Clin. Pharmacokinet. 56(2), 139\u2013152. https:\/\/doi.org\/10.1007\/s40262-016-0432-1 (2017).","journal-title":"Clin. Pharmacokinet."},{"issue":"1","key":"49461_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.14581\/jer.21002","volume":"11","author":"EA Dafe","year":"2021","unstructured":"Dafe, E. A. et al. Effect of lenalidomide on pentylenetetrazole-induced clonic seizure threshold in mice: A role for n-methyl-d-aspartic acid receptor\/nitric oxide pathway. J. Epilepsy Res. 11(1), 6\u201313. https:\/\/doi.org\/10.14581\/jer.21002 (2021).","journal-title":"J. Epilepsy Res."},{"issue":"2","key":"49461_CR20","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00213-013-3152-3","volume":"230","author":"A Easton","year":"2013","unstructured":"Easton, A. et al. Effects of sub-chronic donepezil on brain Abeta and cognition in a mouse model of Alzheimer\u2019s disease. Psychopharmacology 230(2), 279\u2013289. https:\/\/doi.org\/10.1007\/s00213-013-3152-3 (2013).","journal-title":"Psychopharmacology"},{"issue":"5","key":"49461_CR21","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1097\/00001756-199703240-00023","volume":"8","author":"JC Dodart","year":"1997","unstructured":"Dodart, J. C., Mathis, C. & Ungerer, A. Scopolamine-induced deficits in a two-trial object recognition task in mice. Neuroreport 8(5), 1173\u20131178. https:\/\/doi.org\/10.1097\/00001756-199703240-00023 (1997).","journal-title":"Neuroreport"},{"issue":"1","key":"49461_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.29252\/NIRP.BCN.9.1.5","volume":"9","author":"M Rahimzadegan","year":"2018","unstructured":"Rahimzadegan, M. & Soodi, M. Comparison of memory impairment and oxidative stress following single or repeated doses administration of scopolamine in rat hippocampus. Basic Clin. Neurosci. J. 9(1), 5\u201314. https:\/\/doi.org\/10.29252\/NIRP.BCN.9.1.5 (2018).","journal-title":"Basic Clin. Neurosci. J."},{"issue":"9","key":"49461_CR23","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1177\/0271678X20943823","volume":"40","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert, N. et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. J. Cereb. Blood Flow Metab. 40(9), 1769\u20131777 (2020).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"49461_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-1-4939-8994-2_10","volume":"1916","author":"AK Kraeuter","year":"2019","unstructured":"Kraeuter, A. K., Guest, P. C. & Sarnyai, Z. The y-maze for assessment of spatial working and reference memory in mice. Methods Mol. Biol. 1916, 105\u2013111. https:\/\/doi.org\/10.1007\/978-1-4939-8994-2_10 (2019).","journal-title":"Methods Mol. Biol."},{"key":"49461_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00566","volume":"8","author":"V Gimenez De Bejar","year":"2017","unstructured":"Gimenez De Bejar, V., Caballero Bleda, M., Popovi\u0107, N. & Popovi\u0107, M. Verapamil blocks scopolamine enhancement effect on memory consolidation in passive avoidance task in rats. Front. Pharmacol. 8, 566. https:\/\/doi.org\/10.3389\/fphar.2017.00566 (2017).","journal-title":"Front. Pharmacol."},{"issue":"15","key":"49461_CR26","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1016\/j.lfs.2004.07.029","volume":"76","author":"SY Kang","year":"2005","unstructured":"Kang, S. Y. et al. ESP-102, a standardized combined extract of Angelica gigas, Saururus chinensis and Schizandra chinensis, significantly improved scopolamine-induced memory impairment in mice. Life Sci. 76(15), 1691\u20131705. https:\/\/doi.org\/10.1016\/j.lfs.2004.07.029 (2005).","journal-title":"Life Sci."},{"issue":"1\u20133","key":"49461_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ejphar.2009.06.062","volume":"619","author":"SH Kwon","year":"2009","unstructured":"Kwon, S. H., Kim, H. C., Lee, S. Y. & Jang, C. G. Loganin improves learning and memory impairments induced by scopolamine in mice. Eur. J. Pharmacol. 619(1\u20133), 44\u201349. https:\/\/doi.org\/10.1016\/j.ejphar.2009.06.062 (2009).","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"49461_CR28","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.cpan.2025.03.005","volume":"21","author":"M Khedraoui","year":"2025","unstructured":"Khedraoui, M., Guerguer, F. Z., Errougui, A. & Chtita, S. In silico exploration of Aloe vera leaf compounds as dual AChE and BChE inhibitors for Alzheimer\u2019s disease therapy. Curr. Pharm. Anal. 21(4), 238\u2013248. https:\/\/doi.org\/10.1016\/j.cpan.2025.03.005 (2025).","journal-title":"Curr. Pharm. Anal."},{"key":"49461_CR29","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ijbiomac.2022.05.009","volume":"210","author":"KV Dileep","year":"2022","unstructured":"Dileep, K. V. et al. Crystal structure of human acetylcholinesterase in complex with tacrine: Implications for drug discovery. Int. J. Biol. Macromol. 210, 172\u2013181. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.05.009 (2022).","journal-title":"Int. J. Biol. Macromol."},{"key":"49461_CR30","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.18203\/2320-6012.ijrms20241276","volume":"12","author":"MS Hussain","year":"2024","unstructured":"Hussain, M. S. & Mishra, A. K. Advancements in understanding and addressing Alzheimer\u2019s disease: A comprehensive review. Int. J. Res. Med. Sci. 12, 1789\u20131795. https:\/\/doi.org\/10.18203\/2320-6012.ijrms20241276 (2024).","journal-title":"Int. J. Res. Med. Sci."},{"key":"49461_CR31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.12775\/JEHS.2024.56.013","volume":"56","author":"K Wo\u017aniak","year":"2024","unstructured":"Wo\u017aniak, K. et al. Alzheimer\u2019s disease-a comprehensive review. J. Educ. Health Sport 56, 195\u2013209. https:\/\/doi.org\/10.12775\/JEHS.2024.56.013 (2024).","journal-title":"J. Educ. Health Sport"},{"issue":"7","key":"49461_CR32","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1093\/brain\/awac096","volume":"145","author":"E Giacobini","year":"2022","unstructured":"Giacobini, E., Cuello, A. C. & Fisher, A. Reimagining cholinergic therapy for Alzheimer\u2019s disease. Brain 145(7), 2250\u20132275. https:\/\/doi.org\/10.1093\/brain\/awac096 (2022).","journal-title":"Brain"},{"issue":"8","key":"49461_CR33","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.neubiorev.2010.04.001","volume":"34","author":"I Klinkenberg","year":"2010","unstructured":"Klinkenberg, I. & Blokland, A. The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies. Neurosci. Biobehav. Rev. 34(8), 1307\u20131350. https:\/\/doi.org\/10.1016\/j.neubiorev.2010.04.001 (2010).","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"49461_CR34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/s0166-4328(00)00261-8","volume":"115","author":"HC Dringenberg","year":"2000","unstructured":"Dringenberg, H. C. Alzheimer\u2019s disease: More than a \u201ccholinergic disorder\u201d - Evidence that cholinergic-monoaminergic interactions contribute to EEG slowing and dementia. Behav. Brain Res. 115(2), 235\u2013249. https:\/\/doi.org\/10.1016\/s0166-4328(00)00261-8 (2000).","journal-title":"Behav. Brain Res."},{"key":"49461_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2025.1607289","volume":"17","author":"W Ahmad","year":"2025","unstructured":"Ahmad, W., Choe, K., Ahmad, R., Park, T. J. & Kim, M. O. Ambroxol confers neuroprotection against scopolamine-induced Alzheimer\u2019s-like pathology by modulating oxidative stress, neuroinflammation, and cognitive deficits via Nrf-2\/JNK\/GSK-3\u03b2 signaling pathways. Front. Aging Neurosci. 17, 1607289. https:\/\/doi.org\/10.3389\/fnagi.2025.1607289 (2025).","journal-title":"Front. Aging Neurosci."},{"issue":"2","key":"49461_CR36","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s11481-018-9824-3","volume":"14","author":"T Muhammad","year":"2019","unstructured":"Muhammad, T. et al. Melatonin rescue oxidative stress-mediated neuroinflammation\/neurodegeneration and memory impairment in scopolamine-induced amnesia mice model. J. Neuroimmune Pharmacol. 14(2), 278\u2013294. https:\/\/doi.org\/10.1007\/s11481-018-9824-3 (2019).","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"24","key":"49461_CR37","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.2174\/092986708785909067","volume":"15","author":"D Mu\u00f1oz-Torrero","year":"2008","unstructured":"Mu\u00f1oz-Torrero, D. Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer\u2019s disease. Curr. Med. Chem. 15(24), 2433\u20132455. https:\/\/doi.org\/10.2174\/092986708785909067 (2008).","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"49461_CR38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/procel\/pwae026","volume":"16","author":"Q Zheng","year":"2025","unstructured":"Zheng, Q. & Wang, X. Alzheimer\u2019s disease: Insights into pathology, molecular mechanisms, and therapy. Protein Cell 16(2), 83\u2013120. https:\/\/doi.org\/10.1093\/procel\/pwae026 (2025).","journal-title":"Protein Cell"},{"issue":"1","key":"49461_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-40160-2","volume":"13","author":"PC Agu","year":"2023","unstructured":"Agu, P. C. et al. Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in disease management. Sci. Rep. 13(1), 13398. https:\/\/doi.org\/10.1038\/s41598-023-40160-2 (2023).","journal-title":"Sci. Rep."},{"key":"49461_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-05282-9_5","volume-title":"In silico structure-based prediction of receptor\u2013ligand binding affinity: current progress and challenges","author":"SK Panday","year":"2019","unstructured":"Panday, S. K. & Ghosh, I. In silico structure-based prediction of receptor\u2013ligand binding affinity: current progress and challenges (Applications in Preclinical Drug Discovery Process, 2019). https:\/\/doi.org\/10.1007\/978-3-030-05282-9_5."},{"issue":"9","key":"49461_CR41","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1093\/bioinformatics\/btq112","volume":"26","author":"PJ Ballester","year":"2010","unstructured":"Ballester, P. J. & Mitchell, J. B. A machine learning approach to predicting protein\u2013ligand binding affinity with applications to molecular docking. Bioinformatics 26(9), 1169\u20131175. https:\/\/doi.org\/10.1093\/bioinformatics\/btq112 (2010).","journal-title":"Bioinformatics"},{"issue":"20","key":"49461_CR42","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.2174\/1568026618666181025114157","volume":"18","author":"AAT Naqvi","year":"2018","unstructured":"Naqvi, A. A. T., Mohammad, T., Hasan, G. M. & Hassan, M. I. Advancements in docking and molecular dynamics simulations towards ligand-receptor interactions and structure-function relationships. Curr. Top. Med. Chem. 18(20), 1755\u20131768. https:\/\/doi.org\/10.2174\/1568026618666181025114157 (2018).","journal-title":"Curr. Top. Med. Chem."},{"issue":"1","key":"49461_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/pr9010071","volume":"9","author":"OM Salo-Ahen","year":"2020","unstructured":"Salo-Ahen, O. M. et al. Molecular dynamics simulations in drug discovery and pharmaceutical development. Processes 9(1), 71. https:\/\/doi.org\/10.3390\/pr9010071 (2020).","journal-title":"Processes"},{"key":"49461_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2019.00313","volume":"7","author":"YJ Jung","year":"2019","unstructured":"Jung, Y. J., Tweedie, D., Scerba, M. T. & Greig, N. H. Neuroinflammation as a factor of neurodegenerative disease: Thalidomide analogs as treatments. Front. Cell Dev. Biol. 7, 313. https:\/\/doi.org\/10.3389\/fcell.2019.00313 (2019).","journal-title":"Front. Cell Dev. Biol."},{"issue":"11","key":"49461_CR45","doi-asserted-by":"publisher","first-page":"965","DOI":"10.2174\/156802609789630929","volume":"9","author":"GW Caldwell","year":"2009","unstructured":"Caldwell, G. W., Yan, Z., Tang, W., Dasgupta, M. & Hasting, B. ADME optimization and toxicity assessment in early-and late-phase drug discovery. Curr. Top. Med. Chem. 9(11), 965\u2013980. https:\/\/doi.org\/10.2174\/156802609789630929 (2009).","journal-title":"Curr. Top. Med. Chem."},{"issue":"7","key":"49461_CR46","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2174\/1389200222666210705122913","volume":"22","author":"NEH Daoud","year":"2021","unstructured":"Daoud, N. E. H. et al. ADMET profiling in drug discovery and development: Perspectives of in silico, in vitro and integrated approaches. Curr. Drug Metab. 22(7), 503\u2013522. https:\/\/doi.org\/10.2174\/1389200222666210705122913 (2021).","journal-title":"Curr. Drug Metab."},{"key":"49461_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2020.00726","volume":"8","author":"F Wu","year":"2020","unstructured":"Wu, F. et al. Computational approaches in preclinical studies on drug discovery and development. Front. Chem. 8, 726. https:\/\/doi.org\/10.3389\/fchem.2020.00726 (2020).","journal-title":"Front. Chem."},{"issue":"8","key":"49461_CR48","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1002\/ddr.22115","volume":"84","author":"PC Tiwari","year":"2023","unstructured":"Tiwari, P. C., Pal, R., Chaudhary, M. J. & Nath, R. Artificial intelligence revolutionizing drug development: Exploring opportunities and challenges. Drug Dev. Res. 84(8), 1652\u20131663. https:\/\/doi.org\/10.1002\/ddr.22115 (2023).","journal-title":"Drug Dev. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49461-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49461-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49461-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:33:11Z","timestamp":1785882791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49461-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["49461"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-49461-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"4 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"24038"}}